Expression of protease-activated-receptor 2 (PAR-2) in human esophageal mucosa

Scandinavian Journal of Gastroenterology

Volumn 44, Issue 6, 2009, Pages 664-671

  Inci, Kamuran ^a   Edebo, Anders ^a   Olbe, Lars ^a   Casselbrant, Anna ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Adenocarcinoma; Barrett's esophagus; Erosive reflux disease; Mucosa; PAR 2 receptor; Specialized intestinal mucosa; Trypsin

Indexed keywords

PROTEINASE ACTIVATED RECEPTOR 2; TRYPSIN;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ESOPHAGUS MUCOSA; FEMALE; GASTROESOPHAGEAL REFLUX; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADENOCARCINOMA; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION; HUMANS; MALE; METAPLASIA; MIDDLE AGED; MUCOUS MEMBRANE; RECEPTOR, PAR-2;

EID: 67651173299     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520902783683     Document Type: Article

References (25)

1. Kawabata A. Gastrointestinal functions of proteinase-activated receptors. Life Sci 2003;74:247-54.
2. Olbe L. Strong activation of PAR-2 receptors: a common trigger for the development of gastrointestinal adenocarcinomas? Scand J Gastroenterol 2007;42:1133-7.
3. Edebo A. The esophageal mucosa in reflux disease: endoscopic appearance and tissue structure [Thesis]. University of Gothenburg, Sweden; 2007.
4. Richter JE. Gastroesophageal reflux disease. Best Pract Res Clin Gastroenterol 2007;21:609-31.
5. Jankowski JA, Harrison RF, Perry I, Balkwill F, Tselepis C. Barrett's metaplasia. Lancet 2000;356:2079-85.
6. Wild CP, Hardie LJ. Reflux, Barrett's esophagus and adenocarcinoma: burning questions. Nat Rev Cancer 2003; 3:676-84.
7. Yoshida N, Katada K, Handa O, Takagi T, Kokura S, Naito Y, et al. Interleukin-8 production via protease-activated receptor 2 in human esophageal epithelial cells. Int J Mol Med 2007;19:335-40.
8. Kunzelmann K, Sun J, Markovich D, Konig J, Mürle B, Mall M, et al. Control of ion transport in mammalian airways by protease activated receptors type 2 (PAR-2). Faseb J 2005; 19:969-70.
9. Cenac N, Coelho AM, Nguyen C, Compton S, Andrade-GERDon P, MacNaughton WK, et al. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am J Pathol 2002;161:1903-14.
10. Yamashita K, Mimori K, Inoue H, Mori M, Sidransky D. A tumor-suppressive role for trypsin in human cancer progression. Cancer Res 2003;63:6575-8.
11. Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998; 33:1023-9.
12. Edebo A, Vieth M, Tam W, Bruno M, van Berkel AM, Stolte M, et al. Circumferential and axial distribution of esophageal mucosal damage in reflux disease. Dis Esophagus 2007;20: 232-8.
13. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-80.
14. Schmidlin F, Amadesi S, Vidil R, Trevisani M, Martinet N, Caughey G, et al. Expression and function of proteinase-activated receptor 2 in human bronchial smooth muscle. Am J Respir Crit Care Med 2001;164:1276-81.
15. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-54.
16. Vergnolle N. Review article: Proteinase-activated receptors: novel signals for gastrointestinal pathophysiology [review article]. Aliment Pharmacol Ther 2000;14:257-66.
17. Bohm SK, Kong W, Bromme D, Smeekens SP, Anderson DC, Connolly A, et al. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem J 1996;314:1009-16.
18. Nystedt S, Ramakrishnan V, Sundelin J. The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J Biol Chem 1996;271:14910-5.
19. Saifeddine M, al-Ani B, Cheng CH, Wang L, Hollenberg MD. Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. Br J Pharmacol 1996;118:521-30.
20. Al-Ani B, Saifeddine M, Hollenberg MD. Detection of functional receptors for the proteinase-activated-receptor-2-activating polypeptide, SLIGRL-NH2, in rat vascular and gastric smooth muscle. Can J Physiol Pharmacol 1995;73: 1203-7.
21. Hwa JJ, Ghibaudi L, Williams P, Chintala M, Zhang R, Chatterjee M, et al. Evidence for the presence of a proteinase-activated receptor distinct from the thrombin receptor in vascular endothelial cells. Circ Res 1996;78: 581-8.
22. Emilsson K, Wahlestedt C, Sun MK, Nystedt S, Owman C, Sundelin J. Vascular effects of proteinase-activated receptor 2 agonist peptide. J Vasc Res 1997;34:267-72.
23. Damiano BP, Cheung WM, Santulli RJ, Fung-Leung WP, Ngo K, Ye RD, et al. Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. J Pharmacol Exp Ther 1999;288:671-8.
24. Jankowski JA, Harrison RF, Perry I, Balkwill F, Tselepis C. Barrett's metaplasia. Lancet 2000;356:2079-85.
25. Huang SC. Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter. Regul Pept 2007;142:37-43.